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problems. Health workers lack updated medical information and treat-
ment support. Information and Communication Technology (ICT) could 
help tackle this. The impact of ICT on health systems in resource-poor 
countries is likely to be significant and transform the practice of medicine 
just as in high-income countries. However, research for finding the best 
way of doing this is needed. We assessed current approaches to and use 
of ICT among health workers in 2 rural districts of Tanzania in relation 
to the current drug distribution practices, as well as assessing the feasibil-
ity of using ICT to improve ordering and use of medicines.
Patients (or Materials) and Methods: This pilot study was conducted 
in 2010-2011, mapping the drug distribution chain in Tanzania, 
including its problems and barriers. The study was conducted in the 
Bunda and Serengeti districts, both part of a nationally supported 
ICT for rural development project. Health workers involved in drug 
procurement and use at 13 health facilities were interviewed on use 
of and knowledge about ICT, and their attitudes to its use in their 
daily work. They were also showed a potential ICT tool. This tool 
was a prototype application for android tables developed at the KTH 
Royal Institute of Technology in Stockholm. It consisted of 2 parts: 
inventory of drug stock and drug ordering, based on the Tanzanian 
Medical Stores Department (MSD) current paper forms.
Results: Interviewees reported stable drug supply as their main chal-
lenge: Drug supplies were often delayed and incomplete, resulting in 
stock-outs of essential medicines and equipment. The 20 interviewed 
health workers all used mobile phones, 8 of them smartphones that 
they connected to the Internet. All were very positive to the drug-
tracking application, and expressed a great need and wish for con-
tinuous medical education by distance.
Conclusion: New ways to order and distribute drugs, and support 
their use with updated knowledge are increasingly needed as soar-
ing medicine costs and chronic diseases add to the burden on health 
systems. This makes it important to test and evaluate how simple 
ICT technology integrated into the health care system can improve 
the quality of drug ordering, distribution, and use in rural parts of 
Africa. Studying this in a systematic way is pertinent; for example, 
using the Technology Acceptance Model (TAM).
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Introduction: ABCD(2) risk scores are used internationally to triage 
patients for investigation and treatment to reduce high risk of recur-
rent stroke syndromes. Cerebral microemboli detected by transcra-
nial Doppler (TCD) also predict increased risk of acute stroke. We 
studied whether ABCD(2) risk scores predict cerebral microemboli 
in patients with symptomatic carotid artery stenosis.
Patients (or Materials) and Methods: We studied from our Carotid 
Registry 171 patients presenting within 2 weeks of transient 
ischemic attack or minor stroke and found to have critical carotid 
artery stenosis (≥ 50%). Seventy-two (age, 70 [1] [SEM] years; male, 
49; Caucasian, 70) had cerebral microemboli on TCD, of whom 
60 (83%) underwent carotid endarterectomy (CEA). Ninety-nine 
(age, 71 [1]; male, 75; Caucasian, 92) had no TCD microemboli, 
of whom 82 (81%) underwent CEA (controls). Data were analyzed 
using chi-square and Mann-Whitney U tests and receiver operating 
characteristic (ROC) curves.
Results: There was no significant difference in the NICE criterion 
for early assessment (ABCD[2] risk score > 4) for patients with cer-
ebral microemboli versus those without microemboli (53/72 vs 68/99 
patients: odds ratio, 1.27 [95% CI, 0.65–2.50]; P = 0.485). After 
adjusting for preneurological event antiplatelet treatment (APT), 
area under the curve (AUC) of ROC for ABCD(2) risk score showed 
no prediction of cerebral microemboli (no pre-event APT, n = 51: 
AUC, 0.5 [95% CI, 0.325–0.656]; P = 0.914; pre-event APT, n = 
120: AUC, 0.5 [95% CI, 0.415–0.623]; P = 0.72). ABCD(2) risk 
score was < 4 both in 19/72 (26%) embolizing patients and in 31/99 
(31%) controls with critical carotid artery stenosis. The total esti-
mated preventable stroke rate for overlooked embolizing patients and 
those with nonembolizing critical carotid stenosis was 7.8% (95% 
CI, 3.8–11.9), estimated preventable national rate 6080 (95% CI, 
3950–8060), estimated annual UK health and societal cost £670m 
(95% CI, £323 m–£1.01 bn) versus total annual costs of Doppler 
imaging £16m.
Conclusion: ABCD(2) scores did not predict presence of cerebral 
microemboli or carotid disease in more than one quarter of patients 
with symptomatic critical carotid artery stenosis. Based on NICE 
guidelines (refer early if ABCD[2] > 4), assessment for urgent reduc-
tion of high stroke risk may be inappropriately delayed in many 
patients, with a large increase in preventable stroke and financial 
burden on society.
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Introduction: Hospital infections (HIs), frequently associated with hos-
pital treatment, are considered an important factor for increased hos-
pital morbidity, mortality, and overall costs. The aim of this study was 
to review the incidence of HIs, antimicrobial consumption and isolated 
bacteria strain resistance to antibiotics used in the Internal Medicine 
Intensive Care Clinic (IMICC) in the period from 2011 to 2012.
Patients (or Materials) and Methods: Antimicrobial consumption 
was expressed as a number of Defined Daily Doses per 100 bed days 
(DDD/100 b.d.), according to WHO ATC/DDD methodology. The 
incidence of HIs was expressed as the ratio of the total number of 
HIs to total number of patient days (p.d.) (× 1000). The analysis of 
the number of isolated bacterial strains and their resistance to anti-
microbials was based on the data from the Institute for Microbiology 
and Department of Infection Control in the hospital.
Results: Total antimicrobial consumption in IMICC increased from 
51.91 to 56.40 DDD/100 b.d. in 2012. Consumption of ciprofloxacin 
decreased for 20%, while vancomycine and meropenem consumption 
increased for 15% and 30% respectively, in comparison with year 
2011. Consumption of co-trimoxazole and amikacin remained the 
same during observed period. Total number of isolated bacterial strains 
was 237 and 304 in 2011 and 2012, respectively. Most frequently 
isolated bacteria (from blood culture – BC and nonquantitative low 
respiratory tract specimen – NQLRTS) was Acinetobacter spp., which 
resistance to meropenem increased in 2012 (from 50% to 56.10% of 
resistant strains), concomitantly with increased meropenem consump-
tion in this period. Resistance to ciprofloxacin remained high during 
observed period (86.67 vs 92.68% of resistant strains, respectively). 
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Pseudomonas aeruginosa was the second most frequently isolated 
bacteria in IMICC (also from BC and NQLRTS). While its resistance 
to ciprofloxacin remained high, there was a noticeable decrease of P 
aeruginosa resistance to amikacin (73.08 vs 53.13 of resistant strains 
in 2011 and 2012, respectively). In the same period, overall hospital 
infection rate in IMICC decreased from 7.8 to 4.3/1000 p.d.
Conclusion: The causative agents of HIs are specific to each health 
care facility and play an important role to choose specific preventive 
strategy and recommended antimicrobial treatment. Therefore, it 
enables measures for establishing hospital antibiotic policy, in which 
clinical pharmacology unit has an important role.
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